Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Oncology Market

Veterinary Oncology Market Size

  • Report ID: GMI8527
  • Published Date: Mar 2024
  • Report Format: PDF

Veterinary Oncology Market Size

Veterinary Oncology Market size was valued at USD 923.5 million in 2023 and is predicted to reach USD 1.7 billion by 2032, showcasing growth of 7.1% from 2024 – 2032 period. The growth of this market can be attributed to factors such as increasing pet ownership and awareness, significant focus on early detection and diagnosis of cancer in animals, as well as advances in diagnostic tools.

 

Also, growing expenditure on animal healthcare in developed nations, government initiatives for veterinary cancer treatment, and increased adoption of pets are important factors driving market expansion. According to the data provided by the Canadian Animal Health Institute (CAHI) in September 2022, it was reported that approximately 60% of Canadian families owned at least one dog or cat during 2020 to 2022. Thus, with such a sizable population of animals, it is anticipated that the incidence of cancer among them will be elevated, thereby contributing to the expansion of the market.
 

Veterinary oncology is a specialized field of veterinary medicine that focuses on the diagnosis, treatment, and prevention of cancer in animals. It involves the management of cancer in various animal species, including dogs, cats, horses, and other companion animals.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global veterinary oncology industry size was USD 923.5 million in 2023 and is predicted to reach USD 1.7 billion by 2032, due to increasing pet ownership and awareness along with significant focus on early detection and diagnosis of cancer in animals.

The cancer diagnostics & treatment segment recorded 56.2% of the market share in 2023, driven by the strong potential for localized treatment.

North America veterinary oncology market size was USD 400.8 million in 2023 and is anticipated to grow at 6.9% CAGR between 2024

Some of the prominent veterinary oncology firms include AB Science, Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco, NIPPON ZENYAKU KOGYO CO., LTD, PetCure Oncology, Regeneus Ltd, Varian Medical Systems, Inc, and Virbac Corporation.

Veterinary Oncology Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 228
  • Countries covered: 19
  • Pages: 160
 Download Free Sample